Born in Colombia and raised between Mexico and the United States, he trained as a medical doctor and surgeon before working in rural areas, where he developed a deep awareness of the social and human dimensions of health. Driven by the desire to sustainably improve care, he turned to medical innovation, earning a PhD in cardiovascular physiology at Université Paris Cité and later completing a fellowship in interventional cardiology at Sorbonne University. With more than 30 years of experience across the Americas, Europe, and Japan, he has combined research, clinical practice, and international leadership roles in the pharmaceutical and medical device industries. Before joining Sorbonne University, he held executive positions at Sanofi and served as VP of Medical R&D at Air Liquide Healthcare. An active member of European initiatives such as EIT Health and of the bioethics working group of the French Ministry of Health, he is committed to responsible innovation. As founder and director of the Global Health Institute of the Sorbonne University Alliance, he works to transform science into concrete, equitable, and sustainable solutions. A former professor of physiology in Colombia, he remains deeply committed to education, knowledge sharing, and international scientific cooperation to strengthen health systems and improve the lives of the most vulnerable.

Cécilia Bognon-Küss is a philosopher by training and a specialist in the history and philosophy of life sciences. She is currently an assistant professor at Sorbonne University, within the Philosophy Department, attached to the research unit “Sciences, Norms, Democracy“ (UMR 8011). She is responsible for the Master's programme in Biomedical Humanities in the Philosophy department at Sorbonne University and is deputy director of the Institute of Global Health at Sorbonne University. Her research examines the conceptual and historical foundations of biological and medical sciences, with a particular focus on the concepts of nutrition, biological individuality, metabolism, environmental health and the relationship between organisms and their environment. Her approach, which combines the history of philosophy, the history of science and the philosophy of contemporary science, is based on constant dialogue between disciplines.

Anne-Lise Paradis is a CNRS Researcher (PhD, HDR) and an engineer trained at Telecom ParisTech. She is Deputy Head of the Cerebellum, Navigation and Memory Laboratory within the Center for Neuroscience (NeuroSU, Sorbonne University, CNRS, Inserm) at the Institute of Biology Paris-Seine (IBPS). Since 2018, she has served as an expert for ANSES on the committee assessing health risks related to physical agents and emerging technologies, and previously contributed to the working group on 3D technologies and vision (2012–2013).

Claire Rossi has been President of the University of Technology of Compiègne (UTC) since December 2022.
She serves on the board of members of the Sorbonne University Alliance, the board of directors of the Sino-French Institute for Engineering and Technology (UTSEUS) in Shanghai, and the prospective commission of the Regional Economic, Social and Environmental Council (CESER) Hauts-de-France. At the national level, she is vice-president of the “Ecological Transition and Societal Engagement” Commission of the CDEFI (Conference of Directors of French Engineering Schools). She also chairs the supervisory board of UTEAM SA, UTC’s technology transfer subsidiary, and the steering committee of the International Campus UTC-UPT, the Franco-Albanian campus for engineering and innovation in Tirana.

Agnès Mahot is the Secretary General of the Global Health Institute of the Sorbonne University Alliance (ASU-GHI). She holds an MSc in Global Health and International Development, as well as an interdisciplinary Bachelor’s degree in Arts and Sciences (International Development, Psychology). With an international background – from the Congo to the Netherlands, via Southern Europe and the Middle East – she has developed a global perspective on health issues. Her master’s research focused on access to healthcare for undocumented migrants in France. Before joining ASU-GHI, she worked in the non-profit and NGO sectors, notably in fundraising, project coordination, and applied research. Her international and interdisciplinary experience now informs her commitment to building a structured global health expertise within ASU.

Michel Dubois is a Senior Research Fellow at the French National Centre for Scientific Research (CNRS) and Director of the Groupe d’Étude des Méthodes de l’Analyse Sociologique de la Sorbonne (GEMASS), a joint research unit of Sorbonne University and the CNRS. He holds a PhD in Sociology from Sorbonne University and an Habilitation à diriger des recherches in Sociology. Since September 2025, he has served as Director of the French Office for Scientific Integrity (OFIS). Since 2019, he has also directed the social sciences lab Groupe d’Étude des Méthodes de l’Analyse Sociologique de la Sorbonne (GEMASS). Between 2016 and 2019, he conducted his research in the United States as Deputy Director of a CNRS international research unit, first in Los Angeles and later in Washington, DC. During this period, he was also a visiting scholar at UCLA’s Institute for Society and Genetics and at the School of Medicine at George Washington University (GWU). He has held significant editorial responsibilities, including serving as Director of the Revue française de sociologie. Michel Dubois’s research explores the evolving relationship between science and society. His work focuses on transformations in the public image of science and technology, the articulation between social and biological explanations – particularly in environmental epigenetics – and the mechanisms through which scientific knowledge is corrected.

Khadija El Hadri-Zegouah is a professor of Animal Physiology at the Faculty of Science and Engineering of Sorbonne University in Paris. She is affiliated with the “Development, Adaptation, and Aging” (Dev2A) laboratory, where she leads a research project on age-related inflammation within the “Integrative Cellular, Aging and Inflammation” team at the Paris Scène Biology Institute. In addition to her research activities, she is also responsible for the “Nutrition, Quality and Health” (NQS) program in the Master's in Integrative Biology and Physiology. She has extensive experience in setting up and supervising nutritional innovation projects with her Master's 2 students as part of the “Nutrition and Health” course, for which she is responsible within her NQS Master’s program. These projects are developed at the Sorbonne University FabLab in collaboration with startups in the field of nutritional innovation for sustainable food. She has acquired solid experience in providing scientific support and advice to several startups and companies partnering with the NQS master's program. Khadija is involved in two newly created structures, January 2025, as part of the Alliance Sorbonne University. She is deputy director of the Food Initiative and a member of the Executive Committee and coordinator of the Nutrition axis of the Global Health Institute.

As a French Doctor in general practice; PhD in Social Epidemiology, and Professor at Sorbonne University, Jean Sébastien Cadwallader is a member of the ASU-GHI Executive Board. He has worked as a general practitioner at the Aubervilliers Health Center since 2011 and coordinates research on social inequalities in health with the city's public health department. He completed his doctoral studies in INSERM Unit 1178 (Director: Bruno Falissard), where he focused on eating disorders. He teaches qualitative research methods in healthcare, having trained at the Universities of Antwerp and Maastricht, and has been the deputy editor-in-chief of Exercer, the French journal of general practice, since 2013. He is also a member of GROUM-F, the qualitative branch of the CNGE (National College of General Practitioner Teachers), and has authored several books on qualitative research. He conducts qualitative health research on patients in precarious situations. He works within ESSMA (Social Epidemiology and Addictions) and the INsPA in conjunction with the Institute of Global Health.

Dr. Joseph Gligorov is a medical oncologist who currently holds the position of Professor of Medical Oncology at Sorbonne University and practices as a physician in the Medical Oncology Department at Tenon Hospital in Paris (APHP). He is also an integral member of INSERM U938 “Cancer Biology and Treatments” team. Currently, Dr. Gligorov serves as the Executive Director of the APHP–Sorbonne University Cancer Institute. Dr. Gligorov’s main areas of clinical and translational research are breast cancer and the study of predictive factors for patient response to anticancer treatments. He also oversees the organization of the Nice–St Paul de Vence conference, which focuses on developing guidelines for breast cancer treatment. In addition, Dr. Gligorov co-founded and presides over the Mediterranean Association for Radiation Oncology and Medical Oncology (AROMe). This organization aims to improve care for cancer patients, facilitate access to innovative treatments, and promote oncology education in emerging countries of the Mediterranean region.

A professor at Sorbonne University – Pitié-Salpêtrière Hospital, Renaud Piarroux is also Head of the Parasitology and Mycology Department at Pitié-Salpêtrière Hospital. For about thirty years, he has been involved in combating large-scale epidemics around the world, particularly cholera. Notably, at the request of the Haitian government and the French Embassy, he conducted the investigation into the origin of the epidemic that spread throughout the country nine months after the January 2010 earthquake. In this context, he worked with UNICEF and the Haitian Ministry of Health to guide control measures that ultimately led to the elimination of the disease in early 2019. Since the beginning of the Covid-19 pandemic, he has supported the leadership of Assistance Publique–Hôpitaux de Paris in the epidemiological monitoring of the crisis. He is the author of more than 70 international publications on the epidemiology of various infectious diseases and on strategies to control and eliminate them.

Paulo Gadelha is member of the 10-Member Group to support the Technology Facilitation Mechanism with the UN Inter-agency Task Team on STI for the SDGs and Coordinator of the FIOCRUZ Strategy for the 2030 Agenda, Oswaldo Cruz Foundation (FIOCRUZ), Brazil. As coordinator of the FIOCRUZ Strategy for the 2030 Agenda, Dr. Gadelha is in charge of promoting FIOCRUZ’s strategic engagement with the Agenda’s aspirational principles and goals. His background in technology includes studies of the application of technology in public health, healthcare models, and STI’s history. Dr. Gadelha was FIOCRUZ’s president from 2009 to 2016. Previously, he founded and directed “Casa de Oswaldo Cruz”, a FIOCRUZ Institute dedicated to the sociology and history of science and health. Dr. Gadelha served as a member of the National Health Council’s Science and Technology Intersectoral Commission. As President of the Brazilian Association of Collective Health, he chaired the 11th World Congress on Public Health. In 2017, with UN/DESA, he chaired FIOCRUZ’s efforts in organizing the 1st Consultation on Health and STI in the 2030 Agenda’s implementation. (Source)

Zoë Mullan joined The Lancet Global Health as founding Editor-in-Chief in 2013 after working previously as a Senior Editor at The Lancet. She is an Ex-Officio Board Member of the Consortium of Universities for Global Health (USA) and a Scientific Advisory Board member of the Centre for International Health Protection at the Robert Koch Institute (Germany). Between 2013 and 2017, she was a Council Member and Trustee of the Committee on Publication Ethics. She originally trained in Biochemistry at the University of Bath (UK) before joining the publishing industry. She is passionate about health equity, research integrity and publication ethics, and using evidence to improve lives. (Source)

Anca is the Executive Director of the European Patients’ Forum since March 2022. She is a public health advocate working in tobacco control, with expertise in European public health policy and advocacy, and extensive knowledge and experience of EU policy and institutions, advocacy strategies, policy campaigns and project management. Anca has led the Smoke Free Partnership for the past four years, in addition to her 10 years working on pan-European campaigns in SFP. Her almost 20 years of working experience includes the private sector (public affairs consultancy) and the public sector.